Drug
Enasidenib
Enasidenib: highest development phase Phase 2, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Enasidenib Mesylate NCT03825796 | Phase 2 | Recurrent Acute Myeloid Leukemia |
Latest
No recent events.
Follow Enasidenib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.